Markets wobble on second-wave fears
Speculation about a new lockdown in Britain saw the FTSE 100 slide 3.4% on Monday, its worst one-day loss since June.

The eyes of global investors were trained on London this week, but not for good reasons. Speculation about a new lockdown in Britain saw the FTSE 100 slide 3.4% on Monday, its worst one-day loss since June. The drop wiped £52bn off the value of British companies. Concern about a second wave of the pandemic in Spain and France also hit European bourses, with Germany’s Dax falling 4.6% on Monday. The FTSE remained volatile the following day but finished higher as Boris Johnson announced milder measures than many had feared.
Markets were already feeling woozy before this week’s new pandemic restrictions, says Rupert Thompson of wealth manager Kingswood. Global equities ended last week down 4.5% from their early September highs. “Central banks have now spent most of their ammunition,” but politicians are reluctant to provide further fiscal stimulus – in the UK, debate continues about extending furlough schemes beyond October. This week’s turmoil was a reminder that Covid-19 can still rattle investors.
And deservedly so – the new restrictions carry a significant economic cost, says Paul Dales of Capital Economics. We forecast that if this week’s new measures continue for several months then the recovery will be delayed, with the British economy unable to regain “its pre-crisis level until the second half of 2022”. If a two-week “circuit-breaking” lockdown is brought in at some point then GDP will take an immediate 5% hit. That would push back a full recovery until 2023, a year later than if there are no more restrictions.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It’s Britain’s fault!
For Wall Street traders, Monday brought back nasty memories of the crashes in March, say Ben Eisen and Anna Isaac in The Wall Street Journal. A 500-point fall in the Dow Jones index was accompanied by declines in oil and gold prices, a cross-asset washout that sparked “anxiety” about “further turbulence” to come.
Larry Kudlow, Donald Trump’s economic adviser, pointed the finger at Britain, telling a reporter that the market turmoil was “coming out of London” because of “worries that Britain might shut down”. But the US has its own headaches (including the upcoming election) and September is often the start of a “treacherous season”for markets, says Randall Forsyth in Barron’s. From Black Wednesday to Lehman Brothers going bankrupt, the month has a nasty habit of serving up the end-of-summer blues.
Long-suffering British investors have become accustomed to market whiplash. The FTSE All-Share has been “an absolute hound” in recent years, as Russ Mould of AJ Bell notes. Since the Brexit vote in 2016 it has underperformed all other major investment regions on a total returns basis. Even Latin America – where Brazilian turmoil has mingled with an Argentine debt default – has done better. The crucial problem is the FTSE’s heavy exposure to out-of-favour energy and finance stocks. That makes the market a value play by default. British shares are unlikely to shine until the world economy manages to stage a “strong, inflationary recovery”.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
HMRC confirms crypto ETN ISA rules
With crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pensioners targeted in fine wine scams – the tactics to watch for
Wine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?